Most vulnerable children no longer need to shield

Clinical

Most vulnerable children no longer need to shield

In Clinical

The majority of children currently considered extremely clinical vulnerable to coronavirus can now be removed from the shielded patient list, the government says, but only following a consultation with their GP or specialist doctor.

Only a small group of children with certain medical conditions are likely to be advised to shield if shielding needs to be reintroduced in the future.

Independent evidence from the Royal College of Paediatrics and Child Health (RCPCH) shows the risk of serious illness for children and young people is low. There have been far fewer confirmed cases of Covid-19 in children than adults, with children consistently making up less than 2 per cent of total case numbers, says the College.

Infection appears to take a milder course, with mortality at around 0.01 per cent - similar to the incidence seen every year with seasonal flu. There is also emerging evidence that suggests children may be less likely to acquire the disease.

“The importance of children in transmitting the virus is difficult to establish, in particular given the number of asymptomatic cases, but there is some evidence that their role in transmitting the virus is limited. Precise details regarding paediatric transmission cannot be confirmed without widespread sero surveillance, but trends are emerging. Studies of multiple family clusters have revealed children were unlikely to be the index case, in Guangzhou, China, Israel and other countries,” said the RCPCH.

Specialists and GPs are being asked to contact children and their families to discuss shielding over the summer, so families do not need to take any immediate action. The latest guidance for families is in line with the recommendations from the RCPCH and says:

  • A small group of children who receive specialist care in hospitals may need to carry on shielding following a consultation with their doctor. This includes those receiving cancer care or those at risk of severe infection due to an immunodeficiency
  • Most other children who were initially identified as being clinically extremely vulnerable will no longer be considered at highest risk. In particular, children and young people who are cared for just by their GP are very unlikely to need to continue to shield in the long term. This includes children with conditions such as asthma, diabetes, epilepsy and kidney disease.

Record my learning outcomes

Clinical

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Clinical

Pharmacists could manage some emergency admissions

‘Potentially pharmacist-manageable conditions’ accounted for 4.3 per cent of A&E visits in a Canadian study

1 Min Article

bookmark_icon_off
Clinical

Anti-inflammatories boost antidepressants

A meta-analysis of 36 randomised controlled studies suggests that concomitant anti-inflammatories can improve antidepressant effectiveness.

2 Min Article

bookmark_icon_off
Clinical

New class of haemophilia A treatment

The European Commission recently approved emicizumab (Hemlibra) to prevent bleeding episodes in people with severe haemophilia A.

1 Min Article

bookmark_icon_off
Clinical

Nutrition and Covid-19

The Covid-19 pandemic has increased interest in the role of nutrition in immune function and could boost the supplements category in pharmacy.

8 Min Article

bookmark_icon_off
Clinical

Tackling coeliac disease and IBS

Pharmacists can help raise awareness and reduce the gap between the onset and formal diagnosis of coeliac disease and IBS.

14 Min Article

bookmark_icon_off
Clinical

When the drugs don't work

As the evidence stacks up against the use of opioids for chronic pain, there’s a clear role for community pharmacists in helping people.

16 Min Article

Recommended Learning

bookmark_icon_off
Sponsored Education

Advising customers of a unique formulation for a blocked and runny nose from colds

Understand the differences between topical medication for nasal symptoms of the common cold, and topical medication for ongoing nasal problems

34 Min Module

bookmark_icon_off
Sponsored Education

Fungal Nail Roundup

Complete this short interactive module to refresh your knowledge on identifying and treating fungal nail infections, and discover more about a product you can recommend to customers.

5 Min Module

bookmark_icon_off
Sponsored Education

Biological medicines and biosimilars

This module explores biological and biosimilar medicines, and will increase your understanding of the guidelines surrounding the brand prescribing of these drugs and your role in their supply

10 Min Module

bookmark_icon_off
Sponsored Education

Advising on constipation treatments

Discover the key benefits of different types of laxatives, and the right questions to ask customers to ensure you know which to recommend

6 Min Module

bookmark_icon_off
Sponsored Education

Supporting parents of babies with feeding issues

Common feeding feeding issues, including coloc, reflux and regurgitation, and some of the ways they can be managed

20 Min Module

bookmark_icon_off
Bayer Business Programme

Let's talk tech: Using technology to drive your business

This training offers insights into making the most of technology and the commercial opportunities this can offer your business.

 

18 Min Module